Showing results (321-330 of 357) with videos related to

Sort By:
Pageof 36
Vaccine|April 27, 2017
Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controlsJennifer R Verani, Abdullah H Baqui, Claire V Broome, et al.
Vaccines|April 23, 2022
Pivotal Shigella Vaccine Efficacy Trials-Study Design Considerations from a Shigella Vaccine Trial Design Working GroupPatricia B Pavlinac, Elizabeth T Rogawski McQuade, James A Platts-Mills, et al.
Vaccines|October 17, 2020
Whole Genome In-Silico Analysis of South African G1P[8] Rotavirus Strains Before and After Vaccine Introduction Over A Period of 14 YearsPeter N Mwangi, Milton T Mogotsi, Mapaseka L Seheri, et al.
BMJ Open Respiratory Research|June 11, 2019
Chest radiograph reading panel performance in a Bangladesh pneumococcal vaccine effectiveness studyEric D McCollum, Salahuddin Ahmed, Nabidul H Chowdhury, et al.
BMC Infectious Diseases|September 15, 2012
Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trialAndrew Duncan Steele, Kathleen M Neuzil, Nigel A Cunliffe, et al.
Expert Review of Vaccines|April 8, 2010
Global impact of rotavirus vaccinesJacqueline E Tate, Manish M Patel, A Duncan Steele, et al.
The Journal of Infectious Diseases|August 6, 2010
Burden and epidemiology of rotavirus diarrhea in selected African countries: preliminary results from the African Rotavirus Surveillance NetworkJason M Mwenda, Kinkela Mina Ntoto, Almaz Abebe, et al.
Human Vaccines & Immunotherapeutics|February 1, 2021
Challenges and opportunities in setting up a phase III vaccine clinical trial in resource limited settings: Experience from NepalTarun Saluja, Bishnu Rath Giri, Shipra Chaudhary, et al.
Frontiers in Microbiology|January 29, 2021
Whole Genome Analysis of African G12P[6] and G12P[8] Rotaviruses Provides Evidence of Porcine-Human Reassortment at NSP2, NSP3, and NSP4Fortunate Mokoena, Mathew Dioh Esona, Luyanda Mapaseka Seheri, et al.
Vaccine|April 24, 2012
Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan AfricaMilagritos D Tapia, George Armah, Robert F Breiman, et al.
Pageof 36